Ultracompact R-PCR System Reaches the American Biotech Market
By LabMedica International staff writers
Posted on 25 Oct 2011
Biotech and other life science researchers in the United States will soon be able to outfit their laboratories with a new state-of-the-art ultracompact real-time PCR (R-PCR) system.Posted on 25 Oct 2011
Roche (Basel, Switzerland), the world's largest biotech company, will begin marketing the LightCycler Nano real-time PCR system in the US in November 2011.
Image: The LightCycler Nano real-time PCR system (Photo courtesy of Roche).
This compact instrument shares the state-of-the-art technology of the LightCycler portfolio, producing high quality data in qPCR (quantitative R-PCR), genotyping, and high resolution melting on a small platform. The system employs innovative optics and thermal control to provide an extremely low variation of well-to-well performance.
With its 32-well format, the LightCycler Nano is able to fit comfortably on the benchtop. Its easy-to-use software is compatible with both Macintosh and Windows-PC operating systems.
"Many research labs use 96-well instruments, but the average number of samples per run is often below the capacity of the instruments," said Brigitte Fernandes-McAlear, vice president of marketing at Roche. "This compact platform should satisfy the needs of many PCR researchers by fitting well into their work environment while delivering excellent results."
Related Links:
Roche